“EU referendum will have no effect on ratification,” says the UK IPO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

“EU referendum will have no effect on ratification,” says the UK IPO

UPC

A UK IPO spokesperson has told Managing IP that the UK government is pressing ahead with ratifying the UPC Agreement as planned. This news comes after recent speculations that the UK may delay its ratification or even not ratify due to the EU referendum on June 23

In statement sent to Managing IP this morning the UK IPO said:

"The UK's EU referendum will have no effect on UK ratification of the Unified Patent Court Agreement by the middle of 2016. This is in line with the timescale identified for the conclusion of the preparatory work necessary for the UPC to become operational.  Ratification will happen before the Court is expected to open, in early 2017.

“The UK needs to complete implementing legislation before we are ready to ratify and we expect to be ready in time for the Court's expected opening in early 2017.”

CIPA, the body which represents UK patent attorneys, has also published a statement regarding the referendum

It is good news that the UK IPO has come out to reiterate the UK's current position. We hope this will dispel any fears.

You can follow our coverage of the Unitary Patent and UPC, including our new series of UPC case scenarios, at www.managingip.com/upc

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article